An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.
Newcastle University research team develops AI system to personalise treatment outcomes for Merkel cell carcinoma and other aggressive skin cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback